ロード中...
Neutralising capacity against Delta (B.1.617.2) and other variants of concern following Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in health care workers, Israel
SARS-CoV-2 Delta (B.1.617.2) variant of concern (VOC) and other VOCs are spreading in Europe. Micro-neutralisation assays with sera obtained after Comirnaty (BNT162b2, BioNTech/Pfizer) vaccination in 36 healthcare workers (31 female) demonstrated significant fold change reduction in neutralising tit...
保存先:
| 出版年: | Euro Surveill |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
European Centre for Disease Prevention and Control (ECDC)
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8326656/ https://ncbi.nlm.nih.gov/pubmed/34212838 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2807/1560-7917.ES.2021.26.26.2100557 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|